Saratov JOURNAL of Medical and Scientific Research

Evaluation of expenses for treatment of patients with different forms of psoriasis in the conditions of round-the-clock hospital

Year: 2017, volume 13 Issue: №3 Pages: 595-599
Heading: Dermatovenerology Article type: Original article
Authors: Nelyubova O.I., Sazanova G.Yu., Utz S/R.
Organization: Siberian State Medical University
Summary:

 Objective: to evaluate the structure and volume of expenditures on treatment of patients with different clinical forms of psoriasis using the method of analysis of "cost of illness". Material and Methods. The study was conducted on the basis of the Clinic for Skin and Venereal Diseases Medical University of the Saratov State Medical University n.a. V. I. Razumovsky. To determine the costs of treating patients with different clinical forms of psoriasis, 702 medical records of a stationary patient have been analyzed. To assess and analyze the costs of treating patients with psoriasis, one of the methods of clinical and economic analysis was used-the "cost of illness". In the analysis of costs, the costs of inpatient treatment were included, which included direct medical costs, including the payment of medical personnel, the costs of diagnostic, medical manipulation, medicines, the use of medical equipment, inventory, etc.; indirect costs, including the costs of ensuring the activities of the medical institution. The comparative characteristic of the evaluation of the cost of treatment of patients with different forms of psoriasis in accordance with the program of state guarantees and the actual costs of the clinic. Results. It was revealed that the actual cost of the treatment for the completed case of patients with severe forms of psoriasis is 3 times higher than the cost of the treatment under the state guarantees program. The study of the structure of expenditures showed that the main costs are for the purchase of medicines and supplies in severe forms of psoriasis. Conclusion. The difference between the cost of treatment for patients with different forms of psoriasis according to the territorial program of state guarantees of the Saratov region and the actual costs is explained, because the state guarantees program does not take into account comorbid pathology and concomitant diseases, patient's age, which requires additional diagnostic and treatment methods. Analysis of the structure of actual expenditures showed that the maximum share of costs is accounted for by medicines and supplies in severe forms of psoriasis.

Bibliography:
1. Dovzhansky SI, Utz SR. Psoriasis or psoriatic disease. Saratov: Publishing House of Saratov University, 1992; 172 p.
2. Nelyubova Ol, Utz SR. Nozometamorphosis of psoriasis in the Saratov region. Saratov Journal of Medical Scientific Research 2016; 12 (3): 467-475
3. Nelyubova Ol, Utz SR, Sazanova GYu, et al. Cost-effectiveness of therapy in patients with psoriasis (review). Saratov Journal of Medical Scientific Research 2014; 10 (3): 508-511
4. Reshetko OV, Lutsevich КА, Nelyubpva Ol. Pharmacoeconomics as an instrument of clinical pharmacology for optimization of pharmacotherapy (review). Saratov Journal of Medical Scientific Research 2015; 11 (3): 428-431
5. Reshetnikov AV, Shamshurina NG, Alekseeva VM, et al. Application of clinico-economic analysis in medicine: Textbook. M.: GEOTAR-Media, 2009
6. Kory Р, Cindy J, April W. Armstrong Cost-effectiveness analysis of a patient-centered care model for management of psoriasis. American Academy of Dermatology 2012; (4): 563-570
7. Moreno E, Giron F, Martinez M, et al. Optimal treatments in cost-effectiveness analysis in the presence of covariates: Improving patient subgroup definition. European Journal of Operational Research 2013; 226: 173-182
8. Yagudina Rl, Zinchuk lYu, Litvinenko MM. Analysis of the "cost of the disease": types, methodology, features of the conduct in the Russian Federation. Pharmacoeconomics, modern pharmacoeconomics and pharmacoepidemiology 2012; 5 (1): 4-9
9. Avksenteva MV, Vorobyev PA, Yuriev AS, et al. Clinical and economic analysis (evaluation, selection of medical technology and quality management of medical care). Moscow: Newdiamed, 2004; 404 p.
10. Приказ Минздрава РФ от 27 мая 2002 г. № 163 «Об утверждении отраслевого стандарта «Клинико-экономиче-ские исследования. Общие положения»» [Электронный ресурс]. URL: http://www.rspor.ru/mods/norm_doc/mz163_2002. pdf (дата обращения 25.09.2017 г.
11. Постановление Правительства РФ от 19 дек. 2015 г. № 1382 «О Программе государственных гарантий бесплатного оказания гражданам медицинской помощи на 2016 год» [Электронный ресурс]. URL: http://base.garant.ru (дата обращения 25.09.2017 г.
12. Постановление Правительства Саратовской области от 25 дек. 2015 г. № 654-П «О территориальной программе государственных гарантий бесплатного оказания гражданам медицинской помощи в Саратовской области на 2016 год» [Электронный ресурс]. URL: http://base.garant.ru (дата обращения 25.09.2017 г.
13. Yagudina Rl, Litvinenko MM. Analysis of the "cost of disease" as a basic method of pharmacoeconomic research at various levels of the health care system. Bulletin of the Scientific Center for Expertise of Medical Applications 2014; (1): 55-59
14. Shapovalova MA, Bondarev VA, Koretskaya LR. Clinical and economic analysis of the "cost of illness". International Journal of Applied and Fundamental Research 2012; (7): 143-144
15. Avksenteva MV, Vorobiev PA, Gerasimov VB, et al. Economic evaluation of the effectiveness of drug therapy (pharmacoeconomic analysis). Moscow: Newdiamed, 2000; 80 p.

AttachmentSize
2017_03-1_595-599.pdf441.85 KB

No votes yet